👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Mr
Mr Thomas Boon Lam
Urology
English
2,575+
Patients seen
9
Years in practice
10
Publications
1
Languages spoken
About
Mr Thomas Lam became a full-time NHS consultant urological surgeon and honorary senior lecturer at the Department of Urology, Aberdeen Royal Infirmary in 2016. He is majorly interested in robotic radical prostatectomy- prostate cancer, kidney cancer, urinary tract infections and management of lower urinary tract symptoms in males and females. His clinical experience started after he graduated from Leeds School of Medicine on a British Council scholarship in 1997.
Mr Lam had basic surgical training in Leeds and moved to the University of Hull Postgraduate Medical Institute for a clinical research fellowship on Surgical Oncology and Tumour Immunology that led to a PhD degree in 2005. He had a specialist training in Urology through the East of Scotland Training Programme in Urology and it involved moving through Aberdeen and Edinburgh and lately focused on academic urology and laparoscopic pelvic oncology.
In 2011, Mr Lam became a senior clinical lecturer and honorary consultant urological surgeon at the Academic Urology Unit of the University of Aberdeen on a clinical academic portfolio. His specialisation was in clinical trials, evidence synthesis, guideline development and core outcome set development. He has had over 7 million pounds aggregated grant income as chief investigator, co-applicant and co-chief investigator in some clinical trials and projects funded by the government of the U.K.
Mr Lam has over 100 peer-reviewed articles in distinguished journals with Lancet, Lancet Oncology, and European Urology inclusive. He is invited frequently to deliver lectures and teach urological trainees and clinicians at workshops based on his renowned expertise in managing prostate cancer and kidney cancer, in clinical trial methodology, evidence synthesis and clinical guideline development.
He belongs to two associations in charge of clinical practice guidelines issuance to urologists globally for the management of prostate cancer and kidney cancer (the European Association of Urology Prostate Cancer Guideline Panel as well as European Association of Urology Kidney Cancer Guideline Panel). He loves outstanding communication, being able to listen, being humble, and respecting patients and colleagues.
Diseases, Medical Tests and Treatments
• Robotic radical prostatectomy
• Prostate cancer
• Kidney cancer
• Urinary tract infections
• Management of lower urinary tract symptoms
• Robotic radical prostatectomy
• Prostate cancer
• Kidney cancer
• Urinary tract infections
• Management of lower urinary tract symptoms
Mr Lam had basic surgical training in Leeds and moved to the University of Hull Postgraduate Medical Institute for a clinical research fellowship on Surgical Oncology and Tumour Immunology that led to a PhD degree in 2005. He had a specialist training in Urology through the East of Scotland Training Programme in Urology and it involved moving through Aberdeen and Edinburgh and lately focused on academic urology and laparoscopic pelvic oncology.
In 2011, Mr Lam became a senior clinical lecturer and honorary consultant urological surgeon at the Academic Urology Unit of the University of Aberdeen on a clinical academic portfolio. His specialisation was in clinical trials, evidence synthesis, guideline development and core outcome set development. He has had over 7 million pounds aggregated grant income as chief investigator, co-applicant and co-chief investigator in some clinical trials and projects funded by the government of the U.K.
Mr Lam has over 100 peer-reviewed articles in distinguished journals with Lancet, Lancet Oncology, and European Urology inclusive. He is invited frequently to deliver lectures and teach urological trainees and clinicians at workshops based on his renowned expertise in managing prostate cancer and kidney cancer, in clinical trial methodology, evidence synthesis and clinical guideline development.
He belongs to two associations in charge of clinical practice guidelines issuance to urologists globally for the management of prostate cancer and kidney cancer (the European Association of Urology Prostate Cancer Guideline Panel as well as European Association of Urology Kidney Cancer Guideline Panel). He loves outstanding communication, being able to listen, being humble, and respecting patients and colleagues.
Diseases, Medical Tests and Treatments
• Robotic radical prostatectomy
• Prostate cancer
• Kidney cancer
• Urinary tract infections
• Management of lower urinary tract symptoms
• Robotic radical prostatectomy
• Prostate cancer
• Kidney cancer
• Urinary tract infections
• Management of lower urinary tract symptoms
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Mr Thomas Boon Lam
Education & training
-
2007–2013 MD · Medicine and Surgery
-
2013–2017 Residency · Urology
-
2017–2018 Fellowship · Subspecialty training
Career & appointments
-
2017-09–2018-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Urology
Malpractice insurance:
AmTrust Europe · 1,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,940 |
| Annual physical exam | 99395 | 1,706 |
| Vaccination administration | 90471 | 1,842 |
| Minor procedure (skin) | 17110 | 2,949 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 450.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 13 · i10: 8
-
European registry analysis of Urology outcomes
DOI: 10.4176/euroclin.2025.0 · PMID: 31088548 · cited by 60
-
Outcomes of Urology in adults — a multi-centre cohort
DOI: 10.1523/euroclin.2024.1 · PMID: 32931243 · cited by 14
-
European registry analysis of Urology outcomes
DOI: 10.1571/euroclin.2023.2 · PMID: 30754161 · cited by 104
Invited talks
- Practical updates in Urology European Annual Congress (Urology) · Vienna · 2024 · invited
- Single-centre experience in Urology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Urology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2018
- national college of family doctors — Member · since 2018
- European Union of Medical Specialists (UEMS) — Member · since 2018
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Urology
- Awareness When should you see a urology?
For international patients
- Coordinator
- Patient liaison · mr.thomas.lam@euroclinics.example
